Pembrolizumab (additional strength): Solution for infusion 100 mg; Keytruda® Page last updated: 29 May 2017 Public Summary Document (PSD) November 2016 PBAC Meeting - (PDF 169KB) Public Summary Document (PSD) November 2016 PBAC Meeting - (Word 50KB)